Gerard A Hoff, MD
Obstetrics/Gynecology · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center · Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hoff’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G62543 · Current
Licensed to practise in California · since 1988 · expires 2028-03-31 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$12,069
Medicare paid this office $12,069 for 83 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 45 | $4,059 | $74 |
| Return visit (30+ min) | 26 | $3,232 | $111 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Who their Medicare patients are
83 Original Medicare patients in 2024. Average age 73 · Women 100% · Health risk score 0.72. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 59% · Diabetes 14% · Depression 13%.
The office billed $46,652, Medicare allowed $16,774 and paid $12,069; for 126 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 83 | 126 | 73 | 0.72 | $46,652 | $12,069 |
| 2023 | 86 | 145 | 72 | 0.58 | $60,383 | $14,803 |
| 2022 | 84 | 155 | 73 | 0.65 | $44,054 | $12,466 |
| 2021 | 101 | 186 | 74 | 0.76 | $44,368 | $13,457 |
| 2020 | 86 | 153 | 74 | 0.71 | $34,053 | $8,603 |
| 2019 | 102 | 180 | 72 | 0.77 | $52,712 | $13,337 |
| 2018 | 103 | 198 | 72 | 0.80 | $42,202 | $10,838 |
| 2017 | 95 | 201 | 73 | 0.72 | $52,813 | $13,778 |
| 2016 | 103 | 194 | 72 | 0.73 | $57,440 | $12,429 |
| 2015 | 107 | 241 | 73 | 0.72 | $91,324 | $24,305 |
| 2014 | 118 | 228 | 73 | 0.82 | $71,019 | $18,700 |
| 2013 | 99 | 208 | 73 | 0.94 | $52,239 | $14,565 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Short return visit (20+ min) | 62 | $5,626 | $75 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 12 | $576 | $48 |
2022: 2 services
| Short return visit (20+ min) | 53 | $5,545 | $72 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 20 | $944 | $47 |
2021: 2 services
| Short return visit (20+ min) | 76 | $7,552 | $73 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 21 | $1,000 | $48 |
2020: 2 services
| Short return visit (20+ min) | 53 | $3,959 | $57 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 20 | $961 | $48 |
2019: 2 services
| Short return visit (20+ min) | 75 | $5,843 | $61 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 18 | $842 | $47 |
2018: 4 services
| Short return visit (20+ min) | 59 | $4,423 | $58 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 35 | $1,572 | $45 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 18 | $978 | $54 |
| Short return visit | 18 | $496 | $28 |
2017: 3 services
| Short return visit (20+ min) | 62 | $5,150 | $59 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 32 | $1,465 | $46 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 17 | $942 | $55 |
2016: 4 services
| Short return visit (20+ min) | 56 | $4,017 | $55 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 32 | $1,462 | $46 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 17 | $952 | $56 |
| Short return visit | 17 | $614 | $34 |
2015: 4 services
| Short return visit (20+ min) | 65 | $6,227 | $64 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 36 | $1,721 | $48 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 23 | $1,347 | $59 |
| Short return visit | 12 | $356 | $30 |
2014: 4 services
| Short return visit (20+ min) | 71 | $5,200 | $56 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 36 | $1,629 | $45 |
| Return visit (30+ min) | 13 | $1,334 | $95 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 18 | $993 | $55 |
2013: 3 services
| Short return visit (20+ min) | 60 | $6,043 | $64 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 31 | $1,416 | $46 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 15 | $852 | $57 |
Drugs they prescribed that Part D paid
$25,833
Pharmacies billed $25,833 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
243 generic and 42 brand-name prescriptions · $25,833 in drug cost · 19 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 90 | $8,197 | $91 |
| Estradiol (Twice Weekly) | 29 | $2,524 | $87 |
| Yuvafem | 13 | $1,842 | $142 |
| Progesterone | 25 | $1,018 | $41 |
| Clotrimazole-Betamethasone | 14 | $242 | $17 |
See all 6 drugs
| Estradiol | 90 | $8,197 | $91 |
| Estradiol (Twice Weekly) | 29 | $2,524 | $87 |
| Yuvafem | 13 | $1,842 | $142 |
| Progesterone | 25 | $1,018 | $41 |
| Clotrimazole-Betamethasone | 14 | $242 | $17 |
| Oxybutynin Chloride | 12 | $106 | $9 |
Year by year
| 2024 | 285 | 80 | None | 15% | $25,833 |
| 2023 | 252 | 73 | None | 21% | $27,883 |
| 2022 | 243 | 72 | None | 24% | $34,690 |
| 2021 | 229 | 67 | None | 27% | $31,477 |
| 2020 | 182 | 60 | None | 28% | $25,547 |
| 2019 | 211 | 59 | None | 29% | $30,396 |
| 2018 | 211 | 58 | 0% (0) | 36% | $32,514 |
| 2017 | 257 | 62 | None | 51% | $42,384 |
| 2016 | 315 | 74 | None | 53% | $42,346 |
| 2015 | 402 | 72 | None | 50% | $48,193 |
| 2014 | 422 | 75 | None | 49% | $40,584 |
| 2013 | 401 | 76 | None | 50% | $36,707 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Estradiol | 78 | $7,268 | $93 |
| Premarin | 11 | $5,340 | $485 |
| Estradiol (Twice Weekly) | 29 | $3,664 | $126 |
| Yuvafem | 11 | $3,159 | $287 |
| Estradiol (Once Weekly) | 11 | $1,704 | $155 |
| Progesterone | 17 | $729 | $43 |
2022: 4 drugs
| Premarin | 20 | $9,038 | $452 |
| Estradiol | 73 | $8,573 | $117 |
| Estradiol (Twice Weekly) | 23 | $2,832 | $123 |
| Progesterone | 13 | $788 | $61 |
2021: 6 drugs
| Estradiol | 63 | $10,783 | $171 |
| Premarin | 22 | $8,970 | $408 |
| Estradiol (Twice Weekly) | 14 | $2,544 | $182 |
| Estradiol (Once Weekly) | 11 | $1,267 | $115 |
| Progesterone | 13 | $639 | $49 |
| Fluconazole | 12 | $92 | $8 |
2020: 6 drugs
| Estradiol | 29 | $7,271 | $251 |
| Premarin | 17 | $6,056 | $356 |
| Estradiol (Twice Weekly) | 21 | $2,894 | $138 |
| Yuvafem | 12 | $1,992 | $166 |
| Estradiol (Once Weekly) | 11 | $1,882 | $171 |
| Valacyclovir | 16 | $465 | $29 |
2019: 4 drugs
| Estradiol | 67 | $15,397 | $230 |
| Premarin | 26 | $8,565 | $329 |
| Yuvafem | 12 | $1,766 | $147 |
| Oxybutynin Chloride | 16 | $416 | $26 |
2018: 4 drugs
| Estradiol | 58 | $9,807 | $169 |
| Premarin | 31 | $9,378 | $303 |
| Yuvafem | 16 | $4,879 | $305 |
| Valacyclovir | 12 | $370 | $31 |
2017: 6 drugs
| Premarin | 50 | $16,252 | $325 |
| Estring | 14 | $5,287 | $378 |
| Estradiol | 43 | $5,079 | $118 |
| Minivelle | 14 | $1,154 | $82 |
| Valacyclovir | 14 | $328 | $23 |
| Medroxyprogesterone Acetate | 13 | $145 | $11 |
2016: 7 drugs
| Premarin | 71 | $18,825 | $265 |
| Estradiol | 49 | $4,163 | $85 |
| Minivelle | 14 | $2,011 | $144 |
| Valacyclovir | 18 | $588 | $33 |
| Progesterone | 14 | $576 | $41 |
| Medroxyprogesterone Acetate | 12 | $126 | $11 |
| Nortriptyline | 11 | $67 | $6 |
2015: 11 drugs
| Premarin | 92 | $21,786 | $237 |
| Vagifem | 25 | $5,784 | $231 |
| Estrace | 23 | $5,257 | $229 |
| Vivelle-Dot | 11 | $2,479 | $225 |
| Estradiol | 46 | $2,376 | $52 |
| Minivelle | 12 | $1,370 | $114 |
| Valacyclovir | 13 | $1,310 | $101 |
| Progesterone | 16 | $487 | $30 |
| Clotrimazole-Betamethasone | 11 | $455 | $41 |
| Fluconazole | 23 | $299 | $13 |
| Medroxyprogesterone Acetate | 23 | $177 | $8 |
2014: 11 drugs
| Premarin | 74 | $15,022 | $203 |
| Vivelle-Dot | 40 | $4,826 | $121 |
| Vagifem | 32 | $4,619 | $144 |
| Estradiol | 39 | $2,449 | $63 |
| Minivelle | 16 | $1,806 | $113 |
| Progesterone | 15 | $742 | $49 |
| Oxybutynin Chloride | 25 | $436 | $17 |
| Clotrimazole-Betamethasone | 12 | $378 | $31 |
| Alendronate | 11 | $188 | $17 |
| Fluconazole | 17 | $160 | $9 |
| Medroxyprogesterone Acetate | 13 | $133 | $10 |
2013: 11 drugs
| Premarin | 81 | $13,025 | $161 |
| Vivelle-Dot | 48 | $4,360 | $91 |
| Vagifem | 34 | $3,296 | $97 |
| Estrace | 13 | $2,023 | $156 |
| Estradiol | 31 | $1,828 | $59 |
| Progesterone | 24 | $1,385 | $58 |
| Menest | 12 | $331 | $28 |
| Alendronate | 12 | $203 | $17 |
| Medroxyprogesterone Acetate | 17 | $177 | $10 |
| Oxybutynin Chloride | 15 | $158 | $11 |
| Fluconazole | 12 | $131 | $11 |
Money from drug and device companies
$19 in 2019
A payment is not proof that care is biased.
| Hologic | Fluent | $19 | 1 payment
|
See the published payment
| Hologic | Meals · 2019-07-26 | Fluent | $19 |
Professional record
- NPI
- 1831267939
- Licence
- CA G62543California G62543: Current · expires 2028-03-31
- Trained
- University of California, San Diego School of Medicine, 1984
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-11-30
- NPI last updated
- 2022-11-11
- NPI record certified
- 2022-11-11
This is when the NPI record was last certified, not a medical board exam.